Inflammatory bowel disease (IBD) is a term that is used to describe disorders involving chronic inflammation of the digestive tract, such as ulcerative colitis or Crohn’s disease. In this 4-part video series, a panel of experts discuss diagnosis, identifying moderate or severe IBD patients, treatment, and patient education. For additional resources for both patients and care providers, please visit the American Gastroenterological Association (AGA) website.
Disclosure: The faculty received modest honoraria from Frontline Medical Communications for their participation in this roundtable and maintained complete editorial control over all content presented. The views of the faculty do not necessarily reflect those of Frontline Medical Communications, the American Gastroenterological Association (AGA), or the sponsor.
In this video, panelists walk through the diagnosis process. IBD is complex in nature, and the global understanding of the disease is ever-evolving. The roundtable participants discuss the value of different tests that are available to evaluate IBD, and requirements for making ulcerative colitis and Crohn’s disease diagnoses.
This video roundtable was produced by the Custom Programs division of Frontline Medical Communications.
The editorial staff of GI & Hepatology News was not involved in developing the video roundtable.
Dr. Scherl reports research support from AbbVie, AstraZeneca, and Janssen Research & Development; consulting for Janssen, Protagonist Therapeutics, and Seres Therapeutics.
Dr. Swaminath reports research grant support from AbbVie; ad board honoraria from Medtronic and Pfizer.
Drs. Marion and Basu do not report any disclosures.